Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-12

Clinical Trial Update: Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether statins can prevent recurrence of hepatocellular carcinoma after curative treatment; the study is currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Statin (statin)

Snippet

Sponsor: Chiayi Christian Hospital | Conditions: HepatoCellular Carcinoma | Phase 4 | Status: ACTIVE_NOT_RECRUITING